Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GRC 54276 |
Trade Name | |
Synonyms | GRC-54276|GRC54276 |
Drug Descriptions |
GRC 54276 inhibits MAP4K1 (HPK1), potentially resulting in increased antitumor immune response (Cancer Res (2023) 83 (7_Supplement): 463). |
DrugClasses | MAP4K1 Inhibitor 7 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + GRC 54276 | Atezolizumab GRC 54276 | 0 | 1 |
GRC 54276 | GRC 54276 | 0 | 1 |
GRC 54276 + Pembrolizumab | GRC 54276 Pembrolizumab | 0 | 1 |